Novelgen
Find Us
← Back to list
‘Selling and marketing snake oil’: The debate over compounded GLP-1s

‘Selling and marketing snake oil’: The debate over compounded GLP-1s

BioPharma DiveRebecca Pifer ParduhnNovember 18, 2026
Proponents of compounding argue it increases access, lowers prices and helps patients who may need individualized versions of a drug. But there are serious concerns, experts said at the HLTH conference.
Read original article
← Back to list